Exploring the Relationship Between Heart Rate Variability (HRV), Training Load, and Endurance Performance

PepsiCo

Status: Enrolling

Conditions: Heart Rate Variability

Study type: Observational

Funder types: Industry

Identifiers

NCT06964100

PEP-2502

Details and patient eligibility

About

The ability of smart phones, aided by wearable devices (e.g. smart watches), to collect a variety of data, including physical activity, heart rate, and other exercise metrics, may provide a unique opportunity to understand real-world variability. The primary objective of this study is to test user engagement, app functionality, and feasibility of the newly developed Gatorade Sports Science Institute (GSSI) Labs App to conduct Real-World research studies. The secondary purpose of this study is to determine if Training Intensity (%Heart Rate maximum) in minutes during low heart rate variability (HRV) periods (below HRV baseline consecutive days) will have a negative relationship with post-study 5K (5 kilometer) running times as measured by their activity tracker, which could lead to personalized training recommendations using HRV. This study is conducted remotely, there are no in-person visits.

Full description

Heart rate variability (HRV) is an indirect biomarker of an individual's performance readiness and recovery. HRV is a ubiquitous biomarker measured by most consumer-grade wearable fitness trackers. However, there is little documented on the relationship between HRV, training load, and performance measures in the Real-World. Using activity trackers to monitor multiple physiological and subjective measures of health and wellness, subjects will perform self-administered 5 kilometer (5K) timed runs on Week 1, Week 4, and Week 8. Users will be instructed to run their 5K (3.1 miles) on the same outdoor course, indoor track, or treadmill to provide consistency in their performance assessments, with the understanding that there will be some limitations in creating a consistent performance assessment environment (i.e.; weather).

Enrollment: 200 estimated patients

Sex: All

Ages: 18 to 65 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

Actively participating in cardiovascular training (3-5 days/week).

Able to run a 5K (3.1 miles) distance at a self-selected location, three times over 8 weeks.

Age 18-65 years.

Subject is willing to refrain from vigorous exercise (light physical activity only) 24 hours prior to timed 5K assessment.

Subject is willing to avoid alcohol consumption 24 hours prior to 5K assessment.

Subject is willing to provide consent.

Subject is able to continuously wear their activity tracker, including during sleep, except when submerged underwater (i.e., swimming, bathing).

Subjects must have compatible wearable device (Android, Apple Health, Dexcom, Fitbit, Garmin, Health Connect, Oura, Polar, Whoop, and Withings).

Exclusion criteria

Individual has a condition the Investigator believes would interfere with his ability to provide informed consent, comply with the project/study protocol, which might confound the interpretation of the project/study results or put the person at undue risk.

Those with a medical history that would interfere with the results of this study.

Those that have ≥1 risk factor for cardiovascular disease according to the American College of Sports Medicine.

Age: Men ≥ 45 yrs; Women ≥ 55 yrs.

Family History: Heart attack, "bypass surgery", or sudden death before the age of 55 yrs for father/brother, or before 65 yrs for mother/sister.

Cigarette Smoking: Current smoker, or have quit < 6 months, or exposed to environmental smoke.

Sedentary lifestyle: Not participating in moderate (sweating) physical activity at least 3 days/week for 3-months.

Obesity: Body mass index ≥ 30 kg/m2 or waist girth 102 cm (40 inches) for men and 88 cm (35 inches) for women.

Hypertension: Systolic Blood Pressure ≥ 140 mmHg and/or Diastolic ≥90 mmHg, or taking medication.

Dyslipidemia: LDL ≥130 mg/dl, or HDL < 40 mg/dl, or taking medication. Or triglycerides (TG) > 200 > mg/dl.

Pre-diabetes: Impaired fasting glucose (IFG) ≥ 100 mg/dl or oral glucose tolerance test (OGTT) ≥ 140 or ≤ 199 mg/dl confirmed by two different measurements.

Under the care of a physician.

Sleep disorders.

Using prescription medications that would impact sleep.

If female, you are not pregnant, planning to get pregnant or currently breast feeding.

Not able to wear activity tracker continuously.

Lack of proficiency in English.

Lack of proficiency or access to the internet and email address.

Participation in another clinical trial within the past 30 days.

Subject is employed by, or has a parent, guardian, or other immediate family member employed by a company that manufactures any products that compete with any Gatorade product. If subject is unsure if a company would be considered a competitor to Gatorade, they will be asked to please let the study investigator know the name of the other company and the nature of their relationship to that company before they sign the informed consent.